Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its financial results for Q2 2021 on August 5, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its financial results for Q2 2021 on August 5, 2021, after market close. The management will host a conference call at 4:30 PM ET for discussions on the results. Interested parties can join by dialing 888-394-8218 in the U.S. or 323-794-2588 internationally. Opiant develops medications for addictions and drug overdose, including the NARCAN® Nasal Spray. More information can be found on their official website.
Positive
- Opiant has developed NARCAN® Nasal Spray, a leading product in the addiction treatment market.
Negative
- None.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was +3.69%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the second quarter ended June 30, 2021, after the financial markets close on Thursday, August 5, 2021.
The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, August 5, 2021. To access the call, please dial 888-394-8218 in the U.S. or 323-794-2588 outside the U.S. and provide the conference ID number: 5960603. To access the live webcast, please visit http://public.viavid.com/index.php?id=145669. Following the live webcast, an archived version of the call will be available on the website.
Thursday August 5 @ 4:30 pm ET
| Domestic: | 888-394-8218 |
| International: | 323-794-2588 |
| Conference ID: | 5960603 |
| Webcast: | http://public.viavid.com/index.php?id=145669 |
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.
For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.